Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1976 1
1981 2
1982 2
1984 1
1985 1
1986 2
1989 1
1990 1
1991 2
1993 2
1995 1
1998 1
1999 3
2000 1
2001 1
2003 3
2004 7
2005 8
2006 15
2007 7
2008 13
2009 13
2010 15
2011 22
2012 25
2013 22
2014 22
2015 13
2016 26
2017 26
2018 16
2019 21
2020 30
2021 34
2022 27
2023 35
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Results by year

Filters applied: . Clear all
Page 1
Target selection for CAR-T therapy.
Wei J, Han X, Bo J, Han W. Wei J, et al. Among authors: bo j. J Hematol Oncol. 2019 Jun 20;12(1):62. doi: 10.1186/s13045-019-0758-x. J Hematol Oncol. 2019. PMID: 31221182 Free PMC article. Review.
CXCR7 in tumorigenesis and progression.
Hou KL, Hao MG, Bo JJ, Wang JH. Hou KL, et al. Among authors: bo jj. Chin J Cancer. 2010 Apr;29(4):456-9. doi: 10.5732/cjc.009.10404. Chin J Cancer. 2010. PMID: 20346226 Free article. Review.
Clinical development of CAR T cell therapy in China: 2020 update.
Wei J, Guo Y, Wang Y, Wu Z, Bo J, Zhang B, Zhu J, Han W. Wei J, et al. Among authors: bo j. Cell Mol Immunol. 2021 Apr;18(4):792-804. doi: 10.1038/s41423-020-00555-x. Epub 2020 Sep 30. Cell Mol Immunol. 2021. PMID: 32999455 Free PMC article. Review.
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
Li P, Liu Y, Liang Y, Bo J, Gao S, Hu Y, Hu Y, Huang H, Huang X, Jing H, Ke X, Li J, Li Y, Liu Q, Lu P, Mei H, Niu T, Song Y, Song Y, Su L, Tu S, Wang J, Wu D, Wang Z, Xu K, Ying Z, Yang Q, Zhang Y, Shi F, Zhang B, Zhang H, Zhang X, Zhao M, Zhao W, Zhao X, Huang L, Zhu J, Qian W, Han W, Liang A. Li P, et al. Among authors: bo j. Cancer Biol Med. 2023 Mar 2;20(2):129-46. doi: 10.20892/j.issn.2095-3941.2022.0585. Cancer Biol Med. 2023. PMID: 36861439 Free PMC article.
POH1 induces Smad3 deubiquitination and promotes lung cancer metastasis.
Yuan Y, Li Y, Wu X, Bo J, Zhang L, Zhang J, Hu Y, Chen Y, Zeng Y, Wei X, Zhang H. Yuan Y, et al. Among authors: bo j. Cancer Lett. 2024 Feb 1;582:216526. doi: 10.1016/j.canlet.2023.216526. Epub 2023 Dec 5. Cancer Lett. 2024. PMID: 38061486 Free article.
383 results